Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy. [electronic resource]
Producer: 20170818Description: 6673-6678 p. digitalISSN:- 1098-6596
- Acinetobacter baumannii -- drug effects
- Adult
- Aged
- Anti-Bacterial Agents -- therapeutic use
- Bacteremia -- complications
- Case-Control Studies
- Cross Infection -- complications
- Female
- Gram-Negative Bacterial Infections -- complications
- Hematologic Neoplasms -- complications
- Humans
- Immunosuppressive Agents -- adverse effects
- Intensive Care Units
- Length of Stay -- statistics & numerical data
- Levofloxacin -- therapeutic use
- Male
- Middle Aged
- Neutropenia -- complications
- Pseudomonas aeruginosa -- drug effects
- Respiratory Tract Infections -- complications
- Risk Factors
- Stenotrophomonas maltophilia -- drug effects
- Survival Analysis
- Tertiary Care Centers
- Trimethoprim, Sulfamethoxazole Drug Combination -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.